Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05808608
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-25
First Post:
2023-03-23
Brief Title:
A Study of AK104 Plus Axitinib in AdvancedMetastatic Special Pathological Subtypes of Renal Cell Carcinoma
Sponsor:
Hao Zeng
Organization:
West China Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Renal Cell Carcinoma |
| First-line Treatment |
| Non Clear Cell Renal Cell Carcinoma |
| Sarcomatoid Renal Cell Carcinoma |
Keywords: